跳至主要内容
临床试验/JPRN-UMIN000039947
JPRN-UMIN000039947已完成未知

Follow-up of effectiveness in patients with inflammatory bowel diseases treated by ustekinumab and vedolizumab - UV follow-up study in IBD

Saitama Medical Center, Saitama Medical University0 个研究点目标入组 80 人开始时间: 2020年5月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with severe infection 2. Patients with active tuberculosis 3. Patients who has allergy against ustekinumab and vedolizumab 4. Maternal patients and patients with breastfeeding 5. Patients who has malignancy and who has past history of malignancy 6. Patients who has ostomy 7. Patients determined to be inappropriate for this study

研究者

发起方
Saitama Medical Center, Saitama Medical University

相似试验